These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 35537287)
41. Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form. Imamura M; Kato N; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T Microbiol Immunol; 2011 Sep; 55(9):633-40. PubMed ID: 21645053 [TBL] [Abstract][Full Text] [Related]
42. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions. Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946 [TBL] [Abstract][Full Text] [Related]
43. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. Kim JI; Cali I; Surewicz K; Kong Q; Raymond GJ; Atarashi R; Race B; Qing L; Gambetti P; Caughey B; Surewicz WK J Biol Chem; 2010 May; 285(19):14083-7. PubMed ID: 20304915 [TBL] [Abstract][Full Text] [Related]
44. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. Lee CI; Yang Q; Perrier V; Baskakov IV Protein Sci; 2007 Oct; 16(10):2166-73. PubMed ID: 17766375 [TBL] [Abstract][Full Text] [Related]
46. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity. Krasemann S; Neumann M; Szalay B; Stocking C; Glatzel M J Gen Virol; 2013 Feb; 94(Pt 2):453-463. PubMed ID: 23136363 [TBL] [Abstract][Full Text] [Related]
47. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions. Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207 [TBL] [Abstract][Full Text] [Related]
48. Prion-induced and spontaneous formation of transmissible toxicity in PrP transgenic Drosophila. Thackray AM; Di Y; Zhang C; Wolf H; Pradl L; Vorberg I; Andréoletti O; Bujdoso R Biochem J; 2014 Oct; 463(1):31-40. PubMed ID: 25000212 [TBL] [Abstract][Full Text] [Related]
49. Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC. Vascellari S; Orrù CD; Hughson AG; King D; Barron R; Wilham JM; Baron GS; Race B; Pani A; Caughey B PLoS One; 2012; 7(11):e48969. PubMed ID: 23139828 [TBL] [Abstract][Full Text] [Related]
50. Discrimination between L-type and C-type bovine spongiform encephalopathy by the strain-specific reactions of real-time quaking-induced conversion. Ubagai K; Fukuda S; Mori T; Takatsuki H; Taguchi Y; Kageyama S; Nishida N; Atarashi R Biochem Biophys Res Commun; 2020 Jun; 526(4):1049-1053. PubMed ID: 32307081 [TBL] [Abstract][Full Text] [Related]
51. Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions. Imberdis T; Ayrolles-Torro A; Verdier JM; Perrier V Curr Top Med Chem; 2013; 13(19):2477-83. PubMed ID: 24059332 [TBL] [Abstract][Full Text] [Related]
52. A novel, resistance-linked ovine PrP variant and its equivalent mouse variant modulate the in vitro cell-free conversion of rPrP to PrP(res). Kirby L; Goldmann W; Houston F; Gill AC; Manson JC J Gen Virol; 2006 Dec; 87(Pt 12):3747-3751. PubMed ID: 17098994 [TBL] [Abstract][Full Text] [Related]
53. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form. Vanik DL; Surewicz WK J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829 [TBL] [Abstract][Full Text] [Related]
54. Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species. Vieira TC; Reynaldo DP; Gomes MP; Almeida MS; Cordeiro Y; Silva JL J Am Chem Soc; 2011 Jan; 133(2):334-44. PubMed ID: 21142149 [TBL] [Abstract][Full Text] [Related]
55. A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP. Munoz-Montesino C; Larkem D; Barbereau C; Igel-Egalon A; Truchet S; Jacquet E; Nhiri N; Moudjou M; Sizun C; Rezaei H; Béringue V; Dron M J Biol Chem; 2020 Oct; 295(41):14025-14039. PubMed ID: 32788216 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein. Kim DH; Lee HM; Ryou C J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058 [TBL] [Abstract][Full Text] [Related]
57. Ovine recombinant PrP as an inhibitor of ruminant prion propagation in vitro. Workman RG; Maddison BC; Gough KC Prion; 2017 Jul; 11(4):265-276. PubMed ID: 28665745 [TBL] [Abstract][Full Text] [Related]
58. Binding of recombinant but not endogenous prion protein to DNA causes DNA internalization and expression in mammalian cells. Yin S; Fan X; Yu S; Li C; Sy MS J Biol Chem; 2008 Sep; 283(37):25446-25454. PubMed ID: 18622017 [TBL] [Abstract][Full Text] [Related]
59. Generation of genuine prion infectivity by serial PMCA. Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773 [TBL] [Abstract][Full Text] [Related]